Active targeting schemes for nanoparticle systems in cancer therapeutics.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketTargeted therapy using nanotechnology: focus on cancerA New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR EffectLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaRecent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryPolymeric nanoparticles for targeted treatment in oncology: current insightsControlled Drug Release from Pharmaceutical NanocarriersNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewpH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cellsEnhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsLiposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo MoleculesA Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaEnhanced thermal effect using magnetic nano-particles during high-intensity focused ultrasoundLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Synchronized cell attachment triggered by photo-activatable adhesive ligands allows QCM-based detection of early integrin binding.Microfluidic preparation of polymer nanospheres.Triggered drug release from superhydrophobic meshes using high-intensity focused ultrasound.Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells.Nano/microparticles and ultrasound contrast agentsDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detectionNovel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles.Near-infrared phosphorescent polymeric nanomicelles: efficient optical probes for tumor imaging and detectionMiniaturized pre-clinical cancer models as research and diagnostic tools.Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugatesOptical imaging-guided cancer therapy with fluorescent nanoparticlesNanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceiRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.Theranostic tumor homing nanocarriers for the treatment of lung cancerNanoparticle-based drug delivery systems: What can they really do in vivo?Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.Kinetics of nanoparticle targeting by dissipative particle dynamics simulations.Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.Targeted Nanodelivery of Drugs and DiagnosticsNanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.
P2860
Q26745710-2C275972-468D-414E-A507-6DE5A2221A8AQ27006569-CD7E51E9-47D3-4C51-8D62-7B92B83A77BDQ27015050-37A33E68-F73F-4BB0-B52B-9F25275F59FBQ27023361-62D0393B-016B-4FE7-941A-9A77BD4762B9Q27300754-6B1902C9-6FAB-473A-A6AA-7DA49E723FC1Q28068437-AE3C66C7-B387-4D67-BAB9-60DEFB4F4B01Q28079607-3E233F96-BEF3-497A-A588-B09B1B1293D3Q28085280-1C4143BC-C80F-44E9-AC85-951590026DD7Q28087243-7A933971-8D6F-49D8-BC8E-F3E0C542A9ABQ28257050-6EBF6881-AB6D-4F3F-B4E6-2D665847A6E8Q28394719-7F0C78C2-2CDF-4C64-A935-BAE95503BA9CQ28540012-0ACB2642-9B68-4488-B99F-52E0A62CCCF4Q28544700-392A6BA5-C8CA-415F-93B4-FCF6CF1702A2Q28829477-3C748402-4FE4-417E-B774-A58C71EE002FQ30275702-26010AA6-637E-4B44-A0FF-7351D1A73FCAQ30357366-2BBB924E-EEAD-46EC-B47A-D26FA05C2896Q30366990-AF202075-272E-4C17-9004-02793198A22AQ30414823-9E39CB78-AADF-4F48-AF41-67ADDC6C2BD9Q30423470-AC350C5D-1016-495C-983E-8A9CF398E982Q30431665-5F809461-A683-405C-AC01-B0333EF9C850Q30438863-A858E8A5-6354-41F4-9F50-F97D82EF7B25Q30445347-C8A8D162-EBA4-4718-BB66-1D5F100F0BBFQ30472420-E1F95FB0-611F-4E24-A6BC-79D6EA70F444Q30607164-DB26E39A-1D9F-475A-A228-9A36F9A918B6Q33441587-BFB8C58C-5CE1-46CA-9862-717EC0C365C3Q33487116-3399B379-20B8-4B39-A7B4-AC9E1DA30F3BQ33548013-533FD748-4693-4181-8127-76EFFEA5C6B3Q33605145-7F2ED5C1-6B7D-4425-AA7A-F184609AF220Q33622506-D7C04AAB-4A2E-42CF-BFBC-2674B3520535Q33731037-3B6B04E7-4A8C-4D96-9B22-CB7A7EC8FB9FQ33759991-CDF941B4-59BB-4D93-95DF-9E4CB13CCE95Q33766557-19A246C4-0FD7-4D12-BB64-E02E0D146A18Q33769951-641B635F-B2D0-4CC9-A3CA-1ED0C1366056Q33772186-D73D8D8D-B564-4A72-A2F6-1517520322A8Q33834080-D0A5EA2A-DDC2-40D5-9958-C29CED21A8C4Q33837621-5089E5F0-D313-4CEB-8B95-9ABC3082ABEBQ33881923-3CC086E7-1876-4755-9201-10A27624C0BDQ33892483-CEF1CD64-C392-4BF5-8F8B-4489B8D13494Q33900258-935536D1-71CA-49D0-93C7-2E7089F545F1Q33962553-7D9A41AF-7028-44C3-A29D-A8A9D1C9EBF9
P2860
Active targeting schemes for nanoparticle systems in cancer therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@en
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@nl
type
label
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@en
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@nl
prefLabel
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@en
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@nl
P2093
P1476
Active targeting schemes for nanoparticle systems in cancer therapeutics.
@en
P2093
James D Byrne
Lisa Brannon-Peppas
Tania Betancourt
P304
P356
10.1016/J.ADDR.2008.08.005
P407
P577
2008-09-20T00:00:00Z